Structure-preserving integrated analysis for risk stratification with application to cancer staging
Tianjie Wang1, Rui Chen1, Wenshuo Liu2
1Department of Statistics, University of Wisconsin, Madison, WI, USA.
Biostatistics (Oxford, England)
|March 19, 2021
Summary
This study introduces an advanced statistical method for patient stratification, enhancing cancer staging by grouping individuals with similar prognoses. The lasso-tree approach improves data analysis across multiple studies for better healthcare stratification.
Area of Science:
- Biostatistics
- Medical Informatics
- Oncology
Background:
- Effective healthcare requires patient stratification into distinct prognostic groups.
- Current methods like the American Joint Committee on Cancer staging use established risk factors and outcomes.
- Analyzing individual patient data from multiple studies presents challenges due to heterogeneity and unbalanced data.
Purpose of the Study:
- To develop a statistical method for patient grouping using individual patient data from multiple studies.
- To enhance the lasso-tree method by establishing its theoretical properties.
- To improve cancer staging and patient prognosis stratification.
Main Methods:
- Utilizing a strengthened lasso-tree statistical method for patient stratification.
- Incorporating underlying order information in risk factors through lasso-tree parametrization.
- Leveraging individual patient data from multiple studies while accounting for data heterogeneity.
Main Results:
- The enhanced lasso-tree method demonstrates versatility in generating grouping patterns.
- The method effectively handles data heterogeneity and unbalanced structures across studies.
- Simulation studies and breast cancer data analysis validate the method's performance.
Conclusions:
- The proposed statistical method offers a robust approach to patient stratification for improved healthcare.
- This work strengthens the theoretical underpinnings of the lasso-tree method for cancer staging.
- The method facilitates more accurate prognosis assessment and tailored medical interventions.
Related Concept Videos
Cancer Survival Analysis
515
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
515
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
249
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
249
Actuarial Approach
187
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
187
Comparing the Survival Analysis of Two or More Groups
392
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
392


